Carregando...
PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS IN THE 21st CENTURY: FOCUS ON RITUXIMAB
Rheumatoid arthritis (RA) is one of the most common and severe chronic inflammatory diseases. The paper reviews the recent studies evaluating the efficacy of rituximab (MabThera®), chimeric anti-CD20 monoclonal antibodies in B cells, in patients with RA. It has been shown that Rituximab is an extrem...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Russo |
| Publicado em: |
IMA-PRESS LLC
2009-12-01
|
| coleção: | Современная ревматология |
| Assuntos: | |
| Acesso em linha: | https://mrj.ima-press.net/mrj/article/view/261 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|